Dan Kalman

Dan Kalman, PhD is a TB Principal Investigator, Core Faculty, and significant contributor to the BTS Core for TRAC. He is also a Professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. His research goal is to understand how bacterial and viral pathogens interface with the host and overcome defenses. He hopes to use this information to develop novel intervention strategies. The two mechanistic aspects of this interface involve the immunological detection and clearance of the infection, and host systems utilizedby the pathogen to facilitateinfection. His translational work has led him and the AIDS Clinical Trial Group to begin developing a protocol and trial for an FDA-approved anti-cancer therapeutic in humans with multi-drug resistant tuberculosis.